Free Trial

CARGO Therapeutics (CRGX) Competitors

CARGO Therapeutics logo
$4.55 +0.09 (+2.02%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$4.49 -0.06 (-1.30%)
As of 04/15/2025 05:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRGX vs. NRIX, ZYME, GYRE, DAWN, AVXL, PHVS, XERS, NTLA, EOLS, and AVDL

Should you be buying CARGO Therapeutics stock or one of its competitors? The main competitors of CARGO Therapeutics include Nurix Therapeutics (NRIX), Zymeworks (ZYME), Gyre Therapeutics (GYRE), Day One Biopharmaceuticals (DAWN), Anavex Life Sciences (AVXL), Pharvaris (PHVS), Xeris Biopharma (XERS), Intellia Therapeutics (NTLA), Evolus (EOLS), and Avadel Pharmaceuticals (AVDL). These companies are all part of the "pharmaceutical products" industry.

CARGO Therapeutics vs.

CARGO Therapeutics (NASDAQ:CRGX) and Nurix Therapeutics (NASDAQ:NRIX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, community ranking, institutional ownership, earnings and analyst recommendations.

In the previous week, Nurix Therapeutics had 30 more articles in the media than CARGO Therapeutics. MarketBeat recorded 33 mentions for Nurix Therapeutics and 3 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.16 beat Nurix Therapeutics' score of 0.55 indicating that CARGO Therapeutics is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CARGO Therapeutics
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nurix Therapeutics
7 Very Positive mention(s)
4 Positive mention(s)
8 Neutral mention(s)
3 Negative mention(s)
2 Very Negative mention(s)
Positive

CARGO Therapeutics has a net margin of 0.00% compared to Nurix Therapeutics' net margin of -354.85%. CARGO Therapeutics' return on equity of -38.16% beat Nurix Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
CARGO TherapeuticsN/A -38.16% -33.94%
Nurix Therapeutics -354.85%-53.65%-38.59%

CARGO Therapeutics has higher earnings, but lower revenue than Nurix Therapeutics. Nurix Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CARGO TherapeuticsN/AN/A-$98.15M-$3.72-1.21
Nurix Therapeutics$56.42M13.27-$193.57M-$2.80-3.51

CARGO Therapeutics presently has a consensus price target of $15.00, indicating a potential upside of 232.59%. Nurix Therapeutics has a consensus price target of $30.44, indicating a potential upside of 210.02%. Given CARGO Therapeutics' higher possible upside, equities research analysts clearly believe CARGO Therapeutics is more favorable than Nurix Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
Nurix Therapeutics
0 Sell rating(s)
3 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.84

Nurix Therapeutics received 71 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. Likewise, 78.70% of users gave Nurix Therapeutics an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote.

CompanyUnderperformOutperform
CARGO TherapeuticsOutperform Votes
14
66.67%
Underperform Votes
7
33.33%
Nurix TherapeuticsOutperform Votes
85
78.70%
Underperform Votes
23
21.30%

93.2% of CARGO Therapeutics shares are owned by institutional investors. 1.4% of CARGO Therapeutics shares are owned by insiders. Comparatively, 7.2% of Nurix Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

CARGO Therapeutics has a beta of 0.66, meaning that its share price is 34% less volatile than the S&P 500. Comparatively, Nurix Therapeutics has a beta of 2.23, meaning that its share price is 123% more volatile than the S&P 500.

Summary

Nurix Therapeutics beats CARGO Therapeutics on 9 of the 17 factors compared between the two stocks.

Remove Ads
Get CARGO Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRGX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRGX vs. The Competition

MetricCARGO TherapeuticsBiological Products IndustryMedical SectorNASDAQ Exchange
Market Cap$207.70M$2.89B$5.32B$7.56B
Dividend YieldN/A1.91%5.11%4.33%
P/E Ratio-1.0630.8821.7717.81
Price / SalesN/A435.82378.2693.59
Price / CashN/A168.6838.1534.64
Price / Book0.463.476.443.99
Net Income-$98.15M-$72.06M$3.20B$247.23M
7 Day Performance16.84%8.57%6.42%7.24%
1 Month Performance7.13%-17.48%-8.66%-6.26%
1 Year Performance-77.33%-29.58%10.27%-0.18%

CARGO Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRGX
CARGO Therapeutics
2.8565 of 5 stars
$4.55
+2.0%
$15.00
+229.7%
-77.1%$209.54MN/A-1.07116Positive News
NRIX
Nurix Therapeutics
2.1174 of 5 stars
$9.72
+0.3%
$30.88
+217.7%
-36.5%$741.01M$54.55M-3.36300Gap Down
High Trading Volume
ZYME
Zymeworks
2.6506 of 5 stars
$10.43
-4.7%
$21.00
+101.3%
+20.4%$725.69M$76.30M-6.95460Positive News
GYRE
Gyre Therapeutics
0.1333 of 5 stars
$7.62
+10.1%
N/A-49.0%$713.32M$105.76M152.4040Short Interest ↑
High Trading Volume
DAWN
Day One Biopharmaceuticals
2.4554 of 5 stars
$7.02
-2.8%
$32.29
+359.9%
-48.1%$711.51M$131.16M-6.8260Gap Down
AVXL
Anavex Life Sciences
3.5111 of 5 stars
$8.33
+1.7%
$44.00
+428.2%
+115.6%$708.58MN/A-15.1540Positive News
PHVS
Pharvaris
1.4049 of 5 stars
$13.21
-7.5%
$40.50
+206.6%
-30.8%$690.75MN/A-4.7230
XERS
Xeris Biopharma
4.319 of 5 stars
$4.41
flat
$6.10
+38.3%
+136.8%$678.88M$203.07M-9.80290Short Interest ↑
News Coverage
Positive News
Gap Down
High Trading Volume
NTLA
Intellia Therapeutics
4.3268 of 5 stars
$6.54
-1.4%
$37.56
+474.2%
-67.9%$677.00M$57.88M-1.20600Gap Down
High Trading Volume
EOLS
Evolus
3.4956 of 5 stars
$10.24
-4.2%
$24.67
+140.9%
-14.0%$651.13M$266.27M-11.25170Analyst Revision
Positive News
Gap Down
AVDL
Avadel Pharmaceuticals
2.2544 of 5 stars
$6.69
-1.6%
$19.88
+197.1%
N/A$646.45M$169.12M-8.4770Analyst Revision
News Coverage
Gap Down
Remove Ads

Related Companies and Tools


This page (NASDAQ:CRGX) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners